Study, which was published in The Lancet HIV, found that combining 3 medications in a single fixed dose formulation is effective for treating children with HIV.
Researchers at the University of Colorado have contributed to the confirmation of the dose. Safety, and efficacy of a medication formulation intended to treat children infected with the human immunodeficiency virus (HIV).
Also Read: ओडिशा में डॉक्टरों ने गाय के पेट से 30 किलो प्लास्टिक निकाला
The study, which was published in The Lancet HIV, found that combining three medications. It was dolutegravir, abacavir, and lamivudine – in a single fixed dose combination (FDC) formulation. It is safe, well tolerated, and effective for treating children with HIV. Dosing was also reasonable based on the concentrations of each medicine in the blood.
This is the first FDC containing dolutegravir that can be used for children from 13 to 88 pounds. HIV treatment in children has historically been challenging as it requires the use of multiple tablets. Also requires liquids that don’t always taste the best, and can be challenging to administer.
Also Read: 28% tax on online gaming effective from Oct 1, announces FM
HIV (Human Immunodeficiency Virus) is a viral infection that attacks the immune system. It weakens the body’s ability to fight off infections and diseases. If left untreated, HIV can progress to AIDS (Acquired Immunodeficiency Syndrome). Also, it is a severe stage where the immune system is severely compromised, leading to life-threatening illnesses.